skip to Main Content

All Press Releases

2016, 06, 22 — Press release / PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors

Malmö, Sweden, 22 June 2016 You can also download the press release as PDF here PILA PHARMA successfully completes new shares emission and strengthens the Board of Directors PILA PHARMA raises new capital to initiate the clinical assessment of XEN-D0501 as novel anti-diabetic agent PILA PHARMA AB, Malmö, Sweden announced today it has completed a successful new shares emission which will…

read more

PILA PHARMA CEO explains potential of “chili receptor” as diabetes therapy

Dr. Dorte Gram, CEO of PILA PHARMA AB, one of Sweden’s youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence’s insights portfolio, about PILA’s history, its novel diabetes technology and why we should keep an eye on its lead asset that will be taking off with clinical studies in the near future. PILA owns…

read more

Contact us

FÅ PRESSMEDDELANDEN
GET PRESS RELEASES

Back To Top
Search